Investor Information

Ondine Biomedical Inc.

  • Life sciences company headquartered in Vancouver, Canada

  • Leading the charge in breakthrough photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by superbugs

  • Focused on developing and commercializing novel antimicrobial therapies that address significant patient needs, are environmentally safe, provide substantial public health benefits, are easy to deploy, and cost a fraction of the infections they target.

For Media Information

Simon Vane Percy

Amanda Bernard